Upper GI 2017

c. Baseline and sequential samples from patients presenting clinically relevant events may be interrogated to identify predictive or pharmacodynamic associated biomarkers d. Sequential samples of patients presenting initial responses may be used to identify biomarkers associated with sustained response and/ or decreased tumor burden ; or with development of acquired resistance and/ or increased tumor burden

03/28/2017